Q4 2024 Earnings Call Transcript February 11, 2025 Operator: And good day, ladies and gentlemen, and welcome to the Medpace ...

Q4 2024 Earnings Call Transcript February 11, 2025 Operator: Good day, and thank you for standing by. Welcome to the ...

Q4 2024 Earnings Call Transcript February 11, 2025 TPG Inc. misses on earnings expectations. Reported EPS is $-0.06 EPS, ...

Q4 2024 Earnings Call Transcript February 11, 2025 Operator: Good morning, and welcome to the Cincinnati Financial ...

Q4 2024 Earnings Call Transcript February 11, 2025 Royalty Pharma plc misses on earnings expectations. Reported EPS is ...

Q4 2024 Earnings Call Transcript February 11, 2025 The Carlyle Group Inc. misses on earnings expectations. Reported EPS is $0 ...

operating income margin up 2.6 percentage points vs. 28.0% in Q4 2023 FY 2024: Exceeded outlook for sales and adj. EPS; adj. operating income margin improves 1.8 percentage points to 28.7% QIAGEN ...

Q4 2024 Earnings Call Transcript February 11, 2025 Marriott International, Inc. beats earnings expectations. Reported EPS is ...

Q4 2024 Earnings Call Transcript February 11, 2025 IPG Photonics Corporation misses on earnings expectations. Reported EPS is ...

Q4 2024 Earnings Call Transcript February 6, 2025 Operator: Good day, and welcome to the InMode Fourth Quarter and Full Year ...

Preliminary Q4 2024 PEMGARDA™ (pemivibart ... Feb. 03, 2025 (GLOBE NEWSWIRE) -- Invivyd, Inc. (Nasdaq: IVVD), a biopharmaceutical company devoted to delivering protection from serious viral ...

Management expects to file audited annual financial statements and MD&A for fiscal 2024 in April of 2025. The Company is providing investors with preliminary and unaudited Q4/2024 metrics at this ...